Marijuana Business News

Synonyms: 
stocks
business
Mon
14
Jan

3 marijuana stocks to watch in 2019

Cannabis stocks have been very volatile in 2018. Once the best-performing stocks in the market, marijuana stocks have cooled significantly since the legalization of recreational cannabis in Canada on October 17.

At that time, pot stocks were trading near all-time highs. The cannabis bubble has burst since then, and most stock prices have dropped by a fair amount. While risky, the three pot stocks I present could perform well in 2019 following major partnerships they have formed recently.

HEXO (TSX:HEXO)

Hexo focuses on recreational marijuana use and is the only licensed medical marijuana producer headquartered in Quebec.

Fri
11
Jan

Cannapharmarx acquires Alternative Medical Solutions as it prepares to re-enter cannabis space

Cannapharmarx, Inc. has completed its acquisition of Alternative Medical Solutions, Inc. (AMS)—an Ontario-based, late-stage marijuana licensed producer applicant—as part of its efforts to re-enter the cannabis space.

Hanover CPMD Acquisition Corp., a wholly owned subsidiary of Cannapharmarx, Inc., has acquired all issued and outstanding securities of AMS for total consideration of about $12.7 million, consisting of cash, common stock and a promissory note.

Fri
11
Jan

Pot packaging company sees significant growth with legalization

A strain on cash and operations is not a bad thing

CEO Nick Kovacevich has acknowledged that with the sudden growth in sales has added to the company's supply struggles. "While we are confident in the Company's upward trajectory, we acknowledge the impact that our dramatic growth has had on our gross margins, in particular, the utilization of air freight and additional cost incurring quality-control measures at our receiving warehouse to meet demand," he said.

With large markets opening in California and Canada, the company's operations are a bit strained and at the end of November 2018, the company had just $3 million in cash and equivalents on its books, down from the $13.5 million it had in August. But having these kinds of problems isn't necessarily a bad thing.

Fri
11
Jan

Trulieve announces a licensing deal with Sunshine Cannabis to create Eponymous Brand

Trulieve Cannabis Corp. (CSE:TRUL), Florida's premier medical cannabis company, has signed a deal with Sunshine Cannabis to bring a series of products utilizing exclusive genetics to Florida's growing patient population. The Florida-based cannabis company will be collaborating with Trulieve to develop a full suite of premium products based upon proprietary strains developed and preserved by the organization.

Founded in 2013, Sunshine Cannabis is a popular cannabis brand in the Sunshine State known for activism, compassion, and patient advocacy. A Florida-first company committed to providing exceptional medical marijuana products for medical marijuana patients, Sunshine Cannabis is also working to expand legal adult cannabis access statewide.

Fri
11
Jan

Aphria completes acquisition of CC Pharma

“As one of the most promising medical cannabis markets in the world, Germany is a top strategic priority for Aphria,” CEO Vic Neufeld, says in a statement from the Leamington, Ont.-based global cannabis company.

The acquisition of CC Pharma—which distributes pharmaceutical products, including medical cannabis, to 13,000-plus pharmacies in Germany and throughout Europe—is helping Aphria create “a German and, ultimately, pan-European platform that brings together demand, supply and distribution,” Neufeld continues.

Fri
11
Jan

Canadian marijuana stock climbs on sales data

Stellar sales figures propelled a Canadian marijuana stock sharply higher Thursday. Here’s some small stocks making big moves on Thursday, January 10, 2019 (as of 11:30 am EST):

Fri
11
Jan

Marijuana penny stocks: WeedMD and Canopy Rivers dominate

Marijuana penny stocks are up and down today on both US and Canadian markets. Marijuana stocks have been on quite the bull run since the beginning of the year. This week, stocks corrected but there are some that are still shining green. 

Today, we’ll take a closer look at two marijuana penny stocks that are outperforming their competitors today.

Fri
11
Jan

Cannabis Canada Daily: The owner of the world’s biggest pot store is eyeing Ontario

Planet 13 eyes Ontario for retail partnership expansion

Planet 13 Holdings, the operator of the biggest cannabis store in the world, would be open to a joint venture so that it can bring a pot dispensary to Ontario, the company's chief executive Bob Groesbeck told BNN Bloomberg. While Planet 13 isn't participating in Ontario’s retail license lottery, it sees a partnership as a more viable way to enter Canada's most populous province.

Fri
11
Jan

Should you buy HEXO Corp. in 2019?

The marijuana industry's momentum in 2018 picked up in a way that we've simply never seen before. Aside from the fact that a record number of Americans want to see cannabis legalized, according to the newest annual Gallup poll, we witnessed Canada legalize recreational pot, the U.S. give the green light to hemp and hemp-based cannabidiol products, and the U.S. Food and Drug Administration approve its very first cannabis-derived drug.

Fri
11
Jan

This is the best pot stock for growing global demand

On January 8, Cowen analyst Vivien Azer released a report estimating the U.S. marijuana market to be worth between $40 billion and $50 billion. By 2030, it’s expected to reach $80 billion — that’s up from her previous estimate of $75 billion.

In 2017, five million Canadians purchased just shy of $6 billion of cannabis. While the Canadian market is significantly smaller than the U.S., the numbers still imply a whopping $1,200 annual spend per customer. Ultimately, however, the market is expected to top out at roughly $9 billion in Canada.

Pages

Subscribe to RSS - Marijuana Business News